secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001213900-25-028621
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology restructures $14.1M payment obligation to Eisai for LYMPHIR milestone and development costs
--------------------------------------------------------------------------------

- Total owed: $5.9M milestone payment plus $8.23M in development and inventory costs.
- Payment schedule: $2.535M due July 15, 2025; then four monthly $2.35M payments; final $2.198M due Dec 15, 2025.
- Interest at 2% per annum accrues from original due dates until actual payment.
- Parties release each other from claims related to past non-payment; License Agreement otherwise unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025028621/0001213900-25-028621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025028621/ea0237095-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-028621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer